Compare · ELV vs PSNL
ELV vs PSNL
Side-by-side comparison of Elevance Health Inc. (ELV) and Personalis Inc. (PSNL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and PSNL operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $92.91B, about 54.6x PSNL ($1.70B).
- Over the past year, ELV is up 23.1% and PSNL is up 51.5% - PSNL leads by 28.4 points.
- PSNL has been more active in the news (9 items in the past 4 weeks vs 3 for ELV).
- ELV has more recent analyst coverage (23 ratings vs 16 for PSNL).
- Company
- Elevance Health Inc.
- Personalis Inc.
- Price
- $428.56+0.04%
- $15.65-1.70%
- Market cap
- $92.91B
- $1.70B
- 1M return
- +3.42%
- -3.54%
- 1Y return
- +23.10%
- +51.55%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- News (4w)
- 3
- 9
- Recent ratings
- 23
- 16
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Personalis Inc.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. The company has partnership with Berry Genomics; Natera, Inc.; and MapKure, LLC. Personalis, Inc. was founded in 2011 and is headquartered in Menlo Park, California.
Latest ELV
- SEC Form 4 filed by Elevance Health Inc.
- Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
- Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Legal Officer Wessling Erin M covered exercise/tax liability with 349 shares, decreasing direct ownership by 5% to 7,230 units (SEC Form 4)
- EVP & Chief HR Officer Craig Ryan R covered exercise/tax liability with 144 shares, decreasing direct ownership by 2% to 6,530 units (SEC Form 4)
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
Latest PSNL
- SEC Form 425 filed by Personalis Inc.
- SEC Form 8-K filed by Personalis Inc.
- Personalis downgraded by BTIG Research
- Amendment: SEC Form SC 13E3/A filed by Personalis Inc.
- SEC Form CT ORDER filed by Personalis Inc.
- CFO AND COO Tachibana Aaron sold $47,541 worth of shares (2,931 units at $16.22), decreasing direct ownership by 1% to 195,902 units (SEC Form 4) (for withholding tax)
- President and CMO Chen Richard sold $64,848 worth of shares (3,998 units at $16.22), decreasing direct ownership by 2% to 169,882 units (SEC Form 4) to satisfy withholding obligation
- SVP and Chief Legal Officer Moore Stephen Michael sold $33,543 worth of shares (2,068 units at $16.22), decreasing direct ownership by 2% to 90,257 units (SEC Form 4) to satisfy withholding tax
- Chief Executive Officer Hall Christopher M sold $120,985 worth of shares (7,459 units at $16.22), decreasing direct ownership by 3% to 228,527 units (SEC Form 4) (withholding obligation)
- SEC Form SC 13E3 filed by Personalis Inc.